The MBRP CTRA is intended to support human research projects that are likely to have a major impact on therapy by applying promising and well-founded laboratory, preclinical, or clinical research findings to the care of the burn-injured patient.
The proposed research must be relevant to active duty Service members, Veterans, military beneficiaries, and/or the American public.
Inclusion of preliminary data relevant to the proposed clinical research is required.
The proposed study must include clinical research, and may include initial proof of concept trials, studies involving use of human anatomical substances, observational studies, and/or involve some retrospective data analysis. Large randomized clinical trials are discouraged.
Deadlines:
• Pre-Application Deadline: May 15, 2020
• Invitation to Submit an Application: June 18, 2020
• Application Submission Deadline: August 20, 2020
To meet the intent of the FY20 MBRP Clinical Translational Research Award (CTRA) mechanism, an application must propose research that advances the development or refinement of interventions, technologies, or knowledge products that will enable non-medical personnel or medical first responders to provide appropriate burn care closer to the point of injury to enhance the potential for better long-term outcomes. The proposed research must address at least one of the FY20 MBRP CTRA Focus Areas:
1. Burn care solutions for use by a non-medical first responder in a PFC scenario.
2. Burn care solutions for use by the medical first responder in the pre-hospital setting (not necessarily in a PFC scenario).
Independent investigators at all academic levels (or equivalent) may be named as a PI in the application.
The anticipated total costs budgeted for the entire period of performance for an FY20 MBRP CTRA award will not exceed $1.5M. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.
